Search company, investor...
AccessClosure company logo

AccessClosure

accessclosure.com

Founded Year

2002

Stage

Acquired | Acquired

Total Raised

$36.24M

Valuation

$0000 

Revenue

$0000 

About AccessClosure

AccessClosure is a medical device company developing access site management products designed to address challenges in the cardiovascular and peripheral vascular markets. AccessClosure manufactures and distributes the Mynx Vascular Closure Device in the United States as well as in a growing number of countries.

Headquarters Location

645 Clyde Ave

Mountain View, California, 94043,

United States

650-903-1000

Missing: AccessClosure's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: AccessClosure's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing AccessClosure

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AccessClosure is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,383 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

AccessClosure Patents

AccessClosure has filed 1 patent.

The 3 most popular patent topics include:

  • Medical equipment
  • Congenital heart defects
  • Dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/4/2019

3/15/2022

Medical equipment, Congenital heart defects, Hematology, Vascular diseases, Implants (medicine)

Grant

Application Date

3/4/2019

Grant Date

3/15/2022

Title

Related Topics

Medical equipment, Congenital heart defects, Hematology, Vascular diseases, Implants (medicine)

Status

Grant

Latest AccessClosure News

Saranas® Expands Intellectual Property with Key Patent Integrating Bleed Monitoring and Vascular Access Closure Device

Feb 23, 2022

February 23, 2022 08:00 AM Eastern Standard Time HOUSTON--( BUSINESS WIRE )--Saranas, a company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications, announced today that the U.S. Department of Commerce’s United States Patent and Trademark Office (USPTO) has issued them Patent No. 11,224,414 . Titled “Access Closure with Bleed Monitoring,” this key patent allows for embedding a vascular access closure device with the company’s proprietary bleed monitoring technology. Saranas’ Early Bird Bleed Monitoring System® is the first and only FDA-approved device for real-time detection and monitoring of endovascular bleed complications. “As we continue to grow our commercial presence with the Early Bird, we are pleased to secure this important patent that is designed to further expand the implementation of our differentiated bleed monitoring technology,” said Saranas CEO James Reinstein. “This patent award demonstrates Saranas’ commitment to innovation and further strengthens our intellectual property portfolio.” “From vessel injury to failure of obtaining hemostasis with access closure devices, bleeding complications in interventional procedures continue to pose challenges for clinicians,” said Dr. Timothy Henry, Lindner Family Distinguished Chair in Clinical Research and Medical Director of The Carl and Edyth Lindner Center for Research at The Christ Hospital. “Technologies to better manage access site complications are paramount as the continued emergence of percutaneous interventions often require large-bore vascular access.” Dr. Philippe Généreux, interventional cardiologist, commented, "We have been using the Early Bird in our clinical practice for the past two years, and the current design of incorporating a fully functional introducer sheath with bleed detection allows for seamless integration into high-risk interventional cardiovascular procedures. Embedding bleed detection directly onto a vascular closure device is the eventual next step and has the potential to become the standard of care across all types of vascular access procedures.” About the Early Bird Bleed Monitoring System The Early Bird Bleed Monitoring System includes a bleed detection array with integrated electrodes in a fully functional vascular access sheath. The Early Bird is designed to measure changes in bioimpedance to detect and monitor bleeding from vessel injury during endovascular procedures, such as a transcatheter aortic valve replacement (TAVR), hemodynamic support device placement, or other complex endovascular interventions, where the femoral artery or vein is used to obtain vascular access. Visual and audible indicators on the Early Bird notify the clinician of the onset and progression of bleeding events. About Saranas Saranas is a privately held Houston-based medical device company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications. The company’s patented Early Bird Bleed Monitoring System for vascular access procedures enables physicians to mitigate downstream consequences by addressing bleeding complications immediately, improving patient outcomes and lowering healthcare costs. For more information, please visit www.saranas.com . Contacts

AccessClosure Frequently Asked Questions (FAQ)

  • When was AccessClosure founded?

    AccessClosure was founded in 2002.

  • Where is AccessClosure's headquarters?

    AccessClosure's headquarters is located at 645 Clyde Ave, Mountain View.

  • What is AccessClosure's latest funding round?

    AccessClosure's latest funding round is Acquired.

  • How much did AccessClosure raise?

    AccessClosure raised a total of $36.24M.

  • Who are the investors of AccessClosure?

    Investors of AccessClosure include Cardinal Health, ONSET Ventures, Three Arch Partners, New Leaf Venture Partners, Morgenthaler Ventures and 5 more.

  • Who are AccessClosure's competitors?

    Competitors of AccessClosure include Vascular Solutions, Ontex, Zonare Medical Systems, Current Solutions, CV Holdings and 9 more.

Compare AccessClosure to Competitors

C
CV Holdings

CV Holdings is a manufacturer of specialized plastic containers for the pharmaceuticals, consumer products and food service markets.

K
Kalypto Medical

Kalypto Medical, Inc. sells wound-care products.

Skytron Logo
Skytron

Skytron aims to provide clinical equipment for the company's healthcare customers.

C
Calumet Coach

Calumet Coach is a manufacturer of mobile coaches and trailer for CAT, MRI equipment

Lamda Biotech Logo
Lamda Biotech

Lamda Biotech develops and markets specialty research lab supplies and consults for special projects in molecular biology and functional genomics.

A
ACME Health Products

ACME aims to provide supplies and services to the healthcare industry.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.